Subscribe To
cardiovascular proximal anastomosis devices market to surge at 5.7% cagr, reaching us$ 23.6 million by 2030 – tmr report
The growing technological advances in healthcare and increased healthcare spending and favorable reimbursement scenario are expected to drive the grow...
May 25, 2023, 1:30 pm
Cvrx to present at the william blair 43rd annual growth stock conference
MINNEAPOLIS, May 25, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing,...
May 25, 2023, 8:30 am
Novo nordisk (nvo) collaborates for gene-editing therapies
Novo Nordisk (NVO) partners with Life Edit Therapeutics to discover and develop gene-editing therapies for rare and ...
May 24, 2023, 4:28 pm
Bare-metal stents market to achieve remarkable growth, projected at 5.2% cagr, and surpassing usd 4.8 billion by 2031 – tmr study
The growing technological advances in healthcare and the increased prevalence of cardiovascular disease...
May 24, 2023, 8:30 am
cardiol therapeutics earns higher price target from broker as it ends 1q with sufficient cash to advance cardiorx candidate
cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has retained a ‘Buy' rating with an increased price targ...
May 23, 2023, 1:56 pm
Biocardia announces timing of the next data safety monitoring board meeting for the cardiamp cell therapy in heart failure pivotal study
SUNNYVALE, Calif., May 23, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the t...
May 23, 2023, 11:00 am
Verve therapeutics to participate in the stifel 2023 tailoring genes: virtual genetic medicines day
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of ...
May 23, 2023, 10:30 am
Alnylam (alny) reports positive results from apollo-b study
Alnylam (ALNY) announces positive interim analysis results from the phase III APOLLO-B study of patisiran to treat transthyretin-mediated amyloidosis ...
May 22, 2023, 1:35 pm
Wearable injectors market size is projected to surpass usd 20.9 billion by 2032 || cagr of 12.4%
According to Market.us, The market is poised for growth due to the escalating incidence of chronic diseases such as diabetes, ...
May 17, 2023, 10:08 am
Vivus’ qsiva in combination with a digital lifestyle intervention leads to significant weight loss and decreased cardiovascular risk in patients with obesity
— Poster presented at the 30th European Congress on Obesity (ECO 2023) shows addition of QSIVA provides benefits compared with Digital Lifestyle Int...
May 17, 2023, 7:30 am
Precision medicine market size to surpass usd 126.24 billion by 2030 at 12.50% cagr – report by market research future (mrfr)
Precision Medicine Market Trends And Insights By Ecosystem Players (Pharmaceuticals and Biotechnology Companies, Diagnostic Companies, Healthcare IT S...
May 16, 2023, 2:30 pm
Bellerophon provides clinical program update and reports first quarter 2023 financial results
Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse®; Pivotal Top-line Data Expected in Mid-2023 WARREN, N.J., May 15, 202...
May 15, 2023, 8:50 pm
Surgical equipment market size is projected to surpass usd 36.0 bn by 2032 | cagr 8.2%
As Per Market.us Study, The global market for surgical equipment is divided into orthopedic, neurosurgery, Gynecology, and Obstetrics, as well as plas...
May 15, 2023, 1:44 pm
Amarin highlights new data providing potential mechanistic insight into vascepa®/vazkepa® (icosapent ethyl) reduction of cardiovascular events
— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — –Data Further A...
May 12, 2023, 3:00 pm
Aerami therapeutics to present pharmacokinetic data supporting aer-901 (inhaled imatinib) for pulmonary hypertension at the 2023 american thoracic society (ats) international conference
DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing ...
May 11, 2023, 12:00 pm
Applied therapeutics reports first quarter 2023 financial results
Demonstrated Long-term Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial Strengthened Balance Sheet with $30 Million Private Placement ...
May 11, 2023, 11:00 am
cardiometabolic disease market size worth usd 868.45 billion by 2032 at 24% cagr – report by market research future (mrfr)
cardiometabolic Disease Market Trends and Insights By Treatment (Angiotensin-converting Enzyme (ACE) In...
May 10, 2023, 2:45 pm
The global hospital equipment and supplies market size was valued at usd 39.21 billion in 2022 and is projected to reach usd 110.63 billion by 2030, growing at a cagr of 12.21% from 2023 to 2030.| dat
According to a market research study published by Contrive Datum Insights, The medical equipment market includes various segments such as orthopaedic ...
May 10, 2023, 4:00 am
The global hospital equipment and supplies market size was valued at usd 39.21 billion in 2022 and is projected to reach usd 110.63 billion by 2030, growing at a cagr of 12.21% from 2023 to 2030.| dat
According to a market research study published by Contrive Datum Insights, The medical equipment market includes various segments such as orthopaedic ...
May 10, 2023, 4:00 am
The global hospital equipment and supplies market size was valued at usd 39.21 billion in 2022 and is projected to reach usd 110.63 billion by 2030, growing at a cagr of 12.21% from 2023 to 2030.| dat
According to a market research study published by Contrive Datum Insights, The medical equipment market includes various segments such as orthopaedic ...
May 10, 2023, 4:00 am